ArticleFrontiers in endocrinology2023

Triglycerides and leptin soluble receptor: Which one is the target to protect β-cells in patients with type 2 diabetes?

Hana Alzamil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.